The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 02, 2025
Filed:
Jun. 14, 2024
Applicant:
Purdue Pharmaceutical Products L.p., Stamford, CT (US);
Inventors:
Thomas Jorg Mehrling, Hunenberg, CH;
Enrique Maria Ocio, Salamanca, ES;
Assignee:
Purdue Pharmaceutical Products L.P., Stamford, CT (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4184 (2006.01); A61K 31/407 (2006.01); A61K 31/427 (2006.01); A61K 31/502 (2006.01); A61K 31/5377 (2006.01); A61K 31/55 (2006.01); A61K 31/573 (2006.01); A61K 31/58 (2006.01); A61K 31/69 (2006.01); A61K 38/05 (2006.01); A61K 38/06 (2006.01); A61K 39/395 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4184 (2013.01); A61K 31/407 (2013.01); A61K 31/427 (2013.01); A61K 31/502 (2013.01); A61K 31/5377 (2013.01); A61K 31/55 (2013.01); A61K 31/573 (2013.01); A61K 31/58 (2013.01); A61K 31/69 (2013.01); A61K 38/05 (2013.01); A61K 38/06 (2013.01); A61K 39/3955 (2013.01); A61K 45/06 (2013.01);
Abstract
The present invention is directed to a combination comprising a proteasome inhibitor and a compound of formula I or a pharmaceutically acceptable salt thereof: to a pharmaceutical composition and to a kit both comprising said combination, to the combination, composition or kit for use in the treatment of cancer, and to a method of treatment of cancer in a patient in need thereof comprising administering to said patient an effective amount of said combination, composition or kit.